Home NDC 23155-137 Hydrochlorothiazide
Product NDC 23155-137
11-digit product format 231550137
Labeler code 23155
Product ID 23155-137_d2805216-a90f-4695-8597-fdbf92f2d667
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Hydrochlorothiazide
Dosage form TABLET
Route ORAL
Labeler Heritage Pharmaceuticals Inc.
Application ANDA040807
Marketing category ANDA
Marketing start 2011-01-03
Marketing end 0000-00-00
Substance HYDROCHLOROTHIAZIDE
Active strength 13 mg/1
Pharmacologic classes Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
NDC exclude flag E
Listing certified through 2018-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 2 · 76 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A040807-001 HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE 12.5MG TABLET / ORAL 2007-07-20 A040807-002 HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE 25MG TABLET / ORAL 2007-07-20 A040807-003 HYDROCHLOROTHIAZIDE HYDROCHLOROTHIAZIDE 50MG TABLET / ORAL 2007-07-20
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 4 · 123 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A040807-001 HYDROCHLOROTHIAZIDE 12.5MG TABLET / ORAL 2007-07-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A040807-002 HYDROCHLOROTHIAZIDE 25MG TABLET / ORAL 2007-07-20 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A040807-003 HYDROCHLOROTHIAZIDE 50MG TABLET / ORAL 2007-07-20 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A040807-001 HYDROCHLOROTHIAZIDE 12.5MG TABLET / ORAL 2007-07-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A040807-002 HYDROCHLOROTHIAZIDE 25MG TABLET / ORAL 2007-07-20 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A040807-003 HYDROCHLOROTHIAZIDE 50MG TABLET / ORAL 2007-07-20 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A040807-001 HYDROCHLOROTHIAZIDE 12.5MG TABLET / ORAL 2007-07-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A040807-002 HYDROCHLOROTHIAZIDE 25MG TABLET / ORAL 2007-07-20 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A040807-003 HYDROCHLOROTHIAZIDE 50MG TABLET / ORAL 2007-07-20 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A040807-001 HYDROCHLOROTHIAZIDE 12.5MG TABLET / ORAL 2007-07-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A040807-002 HYDROCHLOROTHIAZIDE 25MG TABLET / ORAL 2007-07-20 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A040807-003 HYDROCHLOROTHIAZIDE 50MG TABLET / ORAL 2007-07-20 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A040807-001 HYDROCHLOROTHIAZIDE 12.5MG TABLET / ORAL 2007-07-20 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A040807-002 HYDROCHLOROTHIAZIDE 25MG TABLET / ORAL 2007-07-20 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A040807-003 HYDROCHLOROTHIAZIDE 50MG TABLET / ORAL 2007-07-20 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A040807-001 HYDROCHLOROTHIAZIDE 12.5MG TABLET / ORAL 2007-07-20 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A040807-002 HYDROCHLOROTHIAZIDE 25MG TABLET / ORAL 2007-07-20 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A040807-003 HYDROCHLOROTHIAZIDE 50MG TABLET / ORAL 2007-07-20 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A040807-001 HYDROCHLOROTHIAZIDE 12.5MG TABLET / ORAL AB 2007-07-20 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A040807-002 HYDROCHLOROTHIAZIDE 25MG TABLET / ORAL AB 2007-07-20 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A040807-003 HYDROCHLOROTHIAZIDE 50MG TABLET / ORAL AB 2007-07-20 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A040807-001 HYDROCHLOROTHIAZIDE 12.5MG TABLET / ORAL AB 2007-07-20 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A040807-002 HYDROCHLOROTHIAZIDE 25MG TABLET / ORAL AB 2007-07-20 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A040807-003 HYDROCHLOROTHIAZIDE 50MG TABLET / ORAL AB 2007-07-20 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A040807-001 HYDROCHLOROTHIAZIDE 12.5MG TABLET / ORAL AB 2007-07-20 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A040807-002 HYDROCHLOROTHIAZIDE 25MG TABLET / ORAL AB 2007-07-20 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A040807-003 HYDROCHLOROTHIAZIDE 50MG TABLET / ORAL AB 2007-07-20 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A040807-001 HYDROCHLOROTHIAZIDE 12.5MG TABLET / ORAL AB 2007-07-20 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A040807-002 HYDROCHLOROTHIAZIDE 25MG TABLET / ORAL AB 2007-07-20 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A040807-003 HYDROCHLOROTHIAZIDE 50MG TABLET / ORAL AB 2007-07-20 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A040807-001 HYDROCHLOROTHIAZIDE 12.5MG TABLET / ORAL AB 2007-07-20 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A040807-002 HYDROCHLOROTHIAZIDE 25MG TABLET / ORAL AB 2007-07-20 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A040807-003 HYDROCHLOROTHIAZIDE 50MG TABLET / ORAL AB 2007-07-20 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A040807-001 HYDROCHLOROTHIAZIDE 12.5MG TABLET / ORAL AB 2007-07-20 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A040807-002 HYDROCHLOROTHIAZIDE 25MG TABLET / ORAL AB 2007-07-20 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A040807-003 HYDROCHLOROTHIAZIDE 50MG TABLET / ORAL AB 2007-07-20 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A040807-001 HYDROCHLOROTHIAZIDE 12.5MG TABLET / ORAL AB 2007-07-20 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A040807-002 HYDROCHLOROTHIAZIDE 25MG TABLET / ORAL AB 2007-07-20 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A040807-003 HYDROCHLOROTHIAZIDE 50MG TABLET / ORAL AB 2007-07-20 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A040807-001 HYDROCHLOROTHIAZIDE 12.5MG TABLET / ORAL AB 2007-07-20 8072bd15b7f6…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 3 · 102 observed states.
FDA-Initiated Inactive NDC Indexing# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT 0J48LPH2TH HYDROCHLOROTHIAZIDE TABLET [HERITAGE PHARMACEUTICALS INC.] 4 HYDROCHLOROTHIAZIDE ACTIVE MOIETY 0J48LPH2TH HYDROCHLOROTHIAZIDE TABLET [HERITAGE PHARMACEUTICALS INC.] 4 DIBASIC CALCIUM PHOSPHATE DIHYDRATE INACTIVE INGREDIENT O7TSZ97GEP HYDROCHLOROTHIAZIDE TABLET [HERITAGE PHARMACEUTICALS INC.] 4 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 HYDROCHLOROTHIAZIDE TABLET [HERITAGE PHARMACEUTICALS INC.] 4 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X HYDROCHLOROTHIAZIDE TABLET [HERITAGE PHARMACEUTICALS INC.] 4 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 HYDROCHLOROTHIAZIDE TABLET [HERITAGE PHARMACEUTICALS INC.] 4 SODIUM STARCH GLYCOLATE TYPE A POTATO INACTIVE INGREDIENT 5856J3G2A2 HYDROCHLOROTHIAZIDE TABLET [HERITAGE PHARMACEUTICALS INC.] 4 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ HYDROCHLOROTHIAZIDE TABLET [HERITAGE PHARMACEUTICALS INC.] 4 HYDROCHLOROTHIAZIDE ACTIVE INGREDIENT 0J48LPH2TH HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.] 1 HYDROCHLOROTHIAZIDE ACTIVE MOIETY 0J48LPH2TH HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.] 1 CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE INACTIVE INGREDIENT O7TSZ97GEP HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.] 1 FD&C YELLOW NO. 6 INACTIVE INGREDIENT H77VEI93A8 HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.] 1 LACTOSE MONOHYDRATE INACTIVE INGREDIENT EWQ57Q8I5X HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.] 1 MAGNESIUM STEARATE INACTIVE INGREDIENT 70097M6I30 HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.] 1 SODIUM STARCH GLYCOLATE TYPE A POTATO INACTIVE INGREDIENT 5856J3G2A2 HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.] 1 STARCH, CORN INACTIVE INGREDIENT O8232NY3SJ HYDROCHLOROTHIAZIDE TABLET [PREFERRED PHARMACEUTICALS, INC.] 1